These are purpose-built for transporting temperature-sensitive medications and represent the most reliable option for longer trips
Gauge and length are two of the most important factors in needle size
Pivotal trial result: AOD-9604's Phase 2b trial (536 subjects, 24 weeks) failed its primary endpoint
Medically reviewed by: Jayden Lee, PharmD, EMBA Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes
Distribution studies using radiolabeled [3H]BPC-157 demonstrate rapid and widespread tissue distribution following systemic administration
Downstream observations in models include transcriptional changes consistent with enhanced mitochondrial function and lipid utilization